Evidence map›Paper›PMID 32269458›Full record

ArticleEthnicity & disease2020

Participatory Genomic Testing Can Effectively Disseminate Cardiovascular Pharmacogenomics Concepts within Federally Qualified Health Centers: A Feasibility Study.

Amber Johnson, Stephen Broughton, Lisa Aponte-Soto, Karriem Watson, Carla Da Goia Pinto, Philip Empey, Steven Reis, Robert Winn, Mylynda Massart

Open access · bronzeAbstract read
In one paragraph

Article in Ethnicity & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Amber JohnsonUniversity of Pittsburgh; Pittsburgh, PA.
Stephen BroughtonUniversity of Pittsburgh; Pittsburgh, PA.
Lisa Aponte-SotoUniversity of Illinois Cancer Center at University of Illinois at Chicago, IL.
Karriem WatsonUniversity of Illinois Cancer Center at University of Illinois at Chicago, IL.
Carla Da Goia PintoUniversity of Illinois Cancer Center at University of Illinois at Chicago, IL.
Philip EmpeyUniversity of Pittsburgh; Pittsburgh, PA.
Steven ReisUniversity of Pittsburgh; Pittsburgh, PA.
Robert WinnUniversity of Illinois Cancer Center at University of Illinois at Chicago, IL.
Mylynda MassartUniversity of Pittsburgh; Pittsburgh, PA.
University of Pittsburgh · USUniversity of Illinois Chicago · US

Funding

African American Cardiovascular pharmacogenetic CONsorTium (ACCOuNT): discovery and translationU54MD010723 · NIMHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MELTZER, DAVID O, PERERA, MINOLI A · 2016 to 2020
$9.5M
The University of Pittsburgh's Comparative Effectiveness Research Scholars PrograK12HS019461 · AHRQ · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAPOOR, WISHWA N · 2010 to 2010
$1.9M
AHRQ HHS K12 HS019461NIMHD NIH HHS U54 MD010723
6 · The paper itself

Abstract

Objective: We assessed feasibility of an educational program designed to enhance stakeholder knowledge and perceptions of pharmacogenomics at a federally qualified health center (FQHC). Design: FQHCs have a rich history of providing care to the underserved, but often are not represented by studies evaluating cutting-edge concepts. We used a novel educational platform to provide participatory genomic testing and classroom education. We assessed participant knowledge and perceptions using questionnaires between May and July 2018. Setting: We partnered with a FQHC affiliated with an academic medical center in Chicago. Participants: Using convenience sampling, we recruited 20 providers and 10 community members for a feasibility study. Providers included physicians, physician extenders, community health workers, and patient health navigators. Community members were patients, supporters, and/or FQHC advisory board members. Intervention: Participants had the option to undergo personal genomic testing. Online educational modules included basic genetics, cardiovascular pharmacogenomics, and personalized medicine. Education concluded in a 2-hour live course with case-based discussions. Main Outcome Measures: Our main outcome was testing pilot feasibility. Baseline knowledge and perceptions were compared with post-intervention assessments using descriptive statistics, t tests (or Wilcoxon rank-sum) for continuous variables and chi-squared (or Fisher's exact) for categorical variables. Results: We found that attitudes toward the intervention were positive and remained so after intervention. Our intervention was both feasible and acceptable. Genomics knowledge increased for nearly all participants. Conclusions: We have determined that a pharmacogenomics educational program tailored for an underrepresented community is feasible and acceptable. Outcomes will advise methodology for larger implementation studies.

Indexed as

Decision MakingAdultCardiovascular DiseasesFeasibility StudiesFemaleGenetic TestingHumansMaleMiddle AgedPatient SatisfactionPharmacogeneticsPrecision MedicineResearch DesignSurveys and QuestionnairesCardiovascular DiseaseCommunity-Based Participatory ResearchCommunity Health PartnershipsGenomics ResearchParticipatory Genomics TestingPharmacogenomics

Identifiers

PMID32269458
PMCPMC7138441
OpenAlexW3014964441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.